Here are five points:
1. The global orthopedics products market is expected to reach almost $47 billion by 2020.
2. The potential growth is attributed to increasing sports injuries, osteoarthritis, osteoporosis and obesity as well as the increasing geriatric population.
3. The market will also increase as more people want minimally invasive surgeries.
4. Spine holds the maximum share of the global orthopedic products market, with knee, hips, sports medicine, trauma and dental implants following sequentially.
5. Arthrex, Biomet, NuVasive, Smith & Nephew, Stryker and Zimmer are some companies mentioned in the report.
More articles on devices:
Medtronic short interest drops 1.1%: 5 key notes
LDR launches 30-day public offering: 5 key notes
Histogenics reports Q2 $7.6M loss: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
